This device had the potential to change the cost base of the medical system due to lowering general GP visits. I'm not calling conspiracy, but maybe the FDA didn't want to do that at this time and had it's hands tied. It all gets back to money at the end of the day.
- Forums
- ASX - By Stock
- Ann: Update on US FDA De Novo Classification Request
This device had the potential to change the cost base of the...
-
- There are more pages in this discussion • 294 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online